These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 303389)

  • 1. Interaction of collagen with the factor VIII antigen-activity - von Willebrand factor complex.
    Nyman D
    Thromb Res; 1977 Sep; 11(3):433-8. PubMed ID: 303389
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody to human factor VIII/von Willebrand factor inhibits collagen-induced platelet aggregation and release.
    Tschopp TB; Baumgartner HR; Meyer D
    Thromb Res; 1980 Jan 1-15; 17(1-2):255-9. PubMed ID: 6769178
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.
    Gazengel C; Prieur AM; Jacques C; Buriot D; Nedellec J; Josso F
    Am J Hematol; 1978; 5(4):355-63. PubMed ID: 313704
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VIII/von Willebrand factor has potent lectin activity.
    Booth WJ; Furby FH; Berndt MC; Castaldi PA
    Biochem Biophys Res Commun; 1984 Jan; 118(2):495-501. PubMed ID: 6422929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Relationship between factor VIII and von Willebrand's factor in plasma and serum.
    Koutts J; Gude N; Firkin B
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 8. Von Willebrand factor dependent platelet aggregation and adsorption of factor VIII related antigen by collagen.
    Nyman D
    Thromb Res; 1980 Jan 1-15; 17(1-2):209-14. PubMed ID: 6154982
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of VIII R:Ag and VIII R:WF during thrombin and collagen induced aggregation.
    Sultan Y; Maisonneuve P; Angles-Cano E
    Thromb Res; 1979; 15(3-4):415-25. PubMed ID: 315108
    [No Abstract]   [Full Text] [Related]  

  • 10. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.
    Santoro SA
    Thromb Res; 1981 Mar; 21(6):689-91. PubMed ID: 6791300
    [No Abstract]   [Full Text] [Related]  

  • 11. Localization of factor VIII/von Willebrand factor antigen by immunoelectron microscopy in human endothelial cells using Fab fragments coupled to peroxidase.
    Jeanneau C; Sultan Y
    J Histochem Cytochem; 1982 Nov; 30(11):1091-6. PubMed ID: 6815260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor.
    Baumgartner HR; Tschopp TB; Meyer D
    Br J Haematol; 1980 Jan; 44(1):127-39. PubMed ID: 6769457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor].
    Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
    C R Seances Acad Sci III; 1981 May; 292(18):1055-7. PubMed ID: 6790137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA inhibitor to factor VIII/von Willebrand factor.
    Gralnick HR; Flaum MA; Kessler CM; Zimbler H; Coller BS
    Br J Haematol; 1985 Jan; 59(1):149-58. PubMed ID: 3918558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.